All lobbying filings

SIEMENS MEDICAL SOLUTIONS USA, INC

SIEMENS MEDICAL SOLUTIONS USA, INC filed a Q2 amendment for SIEMENS MEDICAL SOLUTIONS USA, INC on July 28, 2026.

Lobbying for SIEMENS MEDICAL SOLUTIONS USA, INC

All filings by SIEMENS MEDICAL SOLUTIONS USA, INC · Everything SIEMENS MEDICAL SOLUTIONS USA, INC has reported

Filing · LD-2 quarterly report Q2 amendment

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 28, 2026

Expenses

$990,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 9

Budget/Appropriations

H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.

Taxation/Internal Revenue Code

H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.

Trade (domestic/foreign)

Issues related to medical supply chains and procurement; and Issues related to international trade

Tariff (miscellaneous tariff bills)

Issues related to tariffs and supply chain resilience.

Defense

H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.

Medical/Disease Research/Clinical Labs

Issues related to NIH funding; and Issues related to ARPA-H Funding.

Natural Resources

Issues related to critical minerals supply chains and production.

Health Issues

Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy and transparency.

Medicare/Medicaid

S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.

Bills named in this filing 5

H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
H.R. 1
One Big Beautiful Bill Act
H.R. 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
S. 1399
Health Tech Investment Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.